Fauci Says FDA Could Clear Pfizer/Biontech Covid-19 Shot Next Month for Kids Under Five

Seeking Alpha2022-01-20

U.S. President Biden’s chief medical advisor Dr. Anthony Fauci said on Wednesday that the FDA could authorize the Pfizer / BioNTech COVID-19 vaccine next month for children under the age of five.

“My hope is that it’s going to be within the next month or so and not much later than that, but I can’t guarantee that,” Fauci said in an interview with Blue Star Families, a non-profit group formed in support of military families, CNBC reports.

In October, the FDA cleared the Pfizer (PFE)/ BioNTech (BNTX) COVID-19 shot for those aged 5 to 11 years at the ten micrograms dose level.

In another development, an expert panel at the Japanese health ministry authorized the Pfizer (PFE)/ BioNTech (BNTX) COVID-19 shot for children aged 5 to 11 years on Thursday. Accordingly, about 7 million kids in Japan will be eligible to receive the vaccine from March at the earliest following the special approval from the country’s Ministry of Health, Labor and Welfare, Kyodo News reports.

Pfizer (PFE), BioNTech (BNTX), and Moderna (NASDAQ:MRNA) are trading higher in the pre-market after a selloff early this week amid concerns over the efficacy of a second booster shot against the Omicron variant.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • JTA
    2022-01-21
    JTA
    Their profit lock in for the next 5 year 
Leave a comment
1